bromodeoxyuridine has been researched along with ro13-9904 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Amstislavskaya, TG; Chang, YT; Chen, JH; Chen, KH; Ho, YJ; Hung, CS; Liang, KC; Meng, WY; Shen, MS; Tikhonova, MA; Weng, JC | 1 |
Abdel-Daim, MM; El-Sayed, YS; Eldaim, MA; Ibrahim, A | 1 |
3 other study(ies) available for bromodeoxyuridine and ro13-9904
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Ceftriaxone prevents the neurodegeneration and decreased neurogenesis seen in a Parkinson's disease rat model: An immunohistochemical and MRI study.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Brain; Brain Mapping; Bromodeoxyuridine; Ceftriaxone; Disease Models, Animal; Electron Transport Complex IV; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; MPTP Poisoning; Neurodegenerative Diseases; Neurogenesis; Neuroprotective Agents; Rats; Rats, Wistar; Statistics as Topic; Tyrosine 3-Monooxygenase | 2016 |
Nephroprotective efficacy of ceftriaxone against cisplatin-induced subchronic renal fibrosis in rats.
Topics: Actins; Animals; Biomarkers; Bromodeoxyuridine; Ceftriaxone; Cell Proliferation; Cisplatin; Creatinine; Cytoprotection; Disease Models, Animal; Fibrosis; Kidney; Kidney Diseases; Male; Protective Agents; Rats, Wistar; Transforming Growth Factor beta1; Urea; Uric Acid | 2017 |